Public Policy Issue
In the fall of 2018 the U.S. House and Senate passed the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act.
ACS CAN submitted comments to FDA regarding the use of opioids at higher doses, in response to an FDA request for comments.
